Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 1.59% | 154.96 | 0.0% | $1509.75m | |
| NVAX | Novavax, Inc. | 2.55% | 79.18 | 78.2% | $568.86m | |
| AMGN | Amgen, Inc. | -1.11% | 222.54 | 1.4% | $546.33m | |
| GILD | Gilead Sciences, Inc. | -2.18% | 67.34 | 1.0% | $534.08m | |
| BIIB | Biogen, Inc. | -1.22% | 219.60 | 1.8% | $496.23m | |
| BNTX | BioNTech SE | 2.69% | 160.70 | 0.0% | $493.59m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.34% | 605.25 | 2.7% | $434.03m | |
| ILMN | Illumina, Inc. | -3.77% | 331.78 | 3.3% | $370.86m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.23% | 226.58 | 1.9% | $358.72m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -4.71% | 2.63 | 0.7% | $183.85m | |
| EXAS | EXACT Sciences Corp. | -0.42% | 68.89 | 17.9% | $173.71m | |
| INCY | Incyte Corp. | -0.85% | 73.52 | 2.4% | $141.06m | |
| ARNA | Arena Pharmaceuticals, Inc. | -0.29% | 89.63 | 13.7% | $135.69m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -1.37% | 83.70 | 4.2% | $108.53m | |
| CRSP | CRISPR Therapeutics AG | -1.12% | 61.84 | 0.6% | $107.20m |
Company Profile
Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research & Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.